Tetra Bio-Pharma
$0.000200
19
+$0.00+0% Thursday 20:00
Statistics
Day High
0.000001
Day Low
0.000001
52W High
0.0002
52W Low
0.000001
Volume
850
Avg. Volume
0
Mkt Cap
84,672.6
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
31OctExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-41.31MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.
Show more...
CEO
Dr. Guy Chamberland M.Sc., Master Herbal
Employees
33
Country
Canada
ISIN
CA88166Y1007
Listings
0 Comments
Share your thoughts
FAQ
What is Tetra Bio-Pharma stock price today?▼
The current price of TBPMQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Tetra Bio-Pharma stock price performance more closely on the chart.
What is Tetra Bio-Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Tetra Bio-Pharma stocks are traded under the ticker TBPMQ.
Is Tetra Bio-Pharma stock price growing?▼
TBPMQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Tetra Bio-Pharma has showed a +0% increase.
What is Tetra Bio-Pharma market cap?▼
Today Tetra Bio-Pharma has the market capitalization of 84,672.6
What is Tetra Bio-Pharma revenue for the last year?▼
Tetra Bio-Pharma revenue for the last year amounts to 0 USD.
What is Tetra Bio-Pharma net income for the last year?▼
TBPMQ net income for the last year is -41.31M USD.
How many employees does Tetra Bio-Pharma have?▼
As of July 22, 2026, the company has 33 employees.
In which sector is Tetra Bio-Pharma located?▼
Tetra Bio-Pharma operates in the Health & Wellness sector.
When did Tetra Bio-Pharma complete a stock split?▼
The last stock split for Tetra Bio-Pharma was on June 23, 2014 with a ratio of 1:2.
Where is Tetra Bio-Pharma headquartered?▼
Tetra Bio-Pharma is headquartered in Orléans, Canada.